Release Date: 24/07/14 17:24 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 134.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%